Navigation Links
Vein Removal Method Linked to Bypass Results
Date:7/15/2009

More long-term problems seen with minimally invasive technique

WEDNESDAY, July 15 (HealthDay News) -- A study originally designed for a completely different purpose has unearthed a disturbing finding about coronary artery bypass surgery: The way that the vein used for the bypass is removed from the body appears to affect the long-term outcome of the surgery.

People whose veins are removed by the minimally invasive technique called endoscopic harvesting had higher rates of bypass failure, heart attacks and death, according to a report in the July 16 issue of the New England Journal of Medicine.

The finding was entirely unexpected, said study senior author Dr. John H. Alexander, a cardiologist at Duke Clinical Research Institute. The study of 3,000 people who had bypass surgery was designed to determine whether treating the removed veins with a drug would improve results. (It didn't.) Only longer-term analysis of the study data revealed the difference in outcome between veins obtained by endoscopic harvesting and those obtained through conventional surgery.

"The mortality difference did not become apparent for at least nine or 10 months," Alexander said. "No one would have thought you needed a year or more to detect a difference in outcome."

Endoscopic harvesting, which uses a one- or two-inch incision to remove a saphenous vein from a leg, is used in 70 percent of the 450,000 coronary bypass operations done annually in the United States. Conventional surgery, which requires a much longer incision, is used in the other 30 percent of cases. Endoscopic harvesting is popular among surgeons and people having bypasses because it virtually eliminates the risk of infection, excess bleeding and other complications associated with conventional removal.

The journal report does not discuss those advantages. Instead, it focuses on the greater rate of graft failure (46.7 percent versus 38 percent at 18 months), death or heart attack (9.3 percent versus 7.6 percent at three years) and deaths (7.4 percent versus 5.8 percent at three years) seen in those who had endoscopic harvesting.

"This has changed the conversation I have with patients," said Alexander, who does not perform bypass surgery but refers patients for the procedure. "Now we have to be balancing the known short-term benefits of endoscopic harvesting with the long-term risk."

So far, he said, "most patients are still leaning toward having endoscopic harvesting and most surgeons are leaning toward endoscopic harvesting."

People who are candidates for bypass surgery most likely will not be having a conversation with their surgeons about the method of vein removal, Alexander said. Data from the study indicate that "hospitals and surgeons have their preferred technique," and that technique most often is endoscopic harvesting.

"This paper will likely stimulate discussion among surgeons," Alexander said. "But it will not be easy to change standard practice. And it is difficult in our health system to shop around, and I'm not certain it's the right thing to do."

"We have a conundrum," said Dr. T. Bruce Ferguson, chairman of cardiovascular sciences at the East Carolina Heart Institute, a member of the research team. "A technique which is technically more difficult to do but is done more often because it is better for patients now has been linked to outcome in a way that suggests we need to figure out how to improve endoscopic vein harvesting."

The study disclosed "an association, not a direct cause-and-effect relationship," Ferguson said. "The dominos appear to be in a straight line, but we don't know if they are supposed to be that way or just appear to be that way."

There is no obvious solution to the conundrum, he said. "It is incumbent on the cardiac surgical community to determine how to impact the risk-benefit equation so that we eliminate the downside while making the upside even better," Ferguson said.

"Every cardiac surgical group in the country should pay particular attention to the vein harvesting procedure," he said. "We must evaluate these things on an individual patient basis."

Ultimate answers would come only from a large controlled trial with long-term follow-up, comparing results of bypass procedures done with veins removed by the two different methods, Alexander and Ferguson said.

Such a trial would be difficult to do and might raise ethical questions, Ferguson said. "And it would be years before we had results," Alexander added.

The reason for the difference in outcomes is unclear, he said. "The best hypothesis is that some damage is done to the vein in endoscopic harvesting," Alexander said. "What it is and how you might change it are unknown."

More information

Coronary artery bypass surgery is described by the American Heart Association.



SOURCES: John H. Alexander, M.D., cardiologist, Duke Clinical Research Institute, and associate professor, medicine, Duke University Medical Center, Durham, N.C.; T. Bruce Ferguson, M.D., chairman, cardiovascular sciences, East Carolina Heart Institute, Greenville, N.C.; July 16, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Headhunters Lice Removal Service Has Lice in Atlanta on the Run
2. CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program
3. Lumenis High Speed LightSheer(R) Duet(TM) Featured on ABCs Good Morning America Health as the New Gold Standard for Laser Hair Removal
4. Palomar Successful in U.S. Patent Office Re-Examination of Hair Removal Patent
5. Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device
6. Pain-Free, Hair-Free System Set to Transform Hair Removal
7. QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court
8. Palomar Wins Two European Hair Removal Patent Opposition Hearings
9. Lice Removal Salon Offers San Diego an Upscale Solution to an Undesirable Problem
10. TRIA Laser Hair Removal System Debuts on The Doctors
11. Palomar Medical to Market Quantels SINON Tattoo Removal Laser in the United States and Canada
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vein Removal Method Linked to Bypass Results
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: